documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
259 rows where agency_id = "FDA", document_type = "Notice" and posted_year = 2000 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2000-N-0039-0001 | FDA | Hepatitis B Surface Antigen;Agency Information Collection FDA-2000-N-0039 | Agency Information Collection Activities; Proposed Collection; Comment Request; Shipment of a Blood Product Prior to Completion of Testing for Hepatitis B Surface Antigen (HBsAg); and Shipment of Blood Products Known Reactive for HBsAg | Notice | General Notice | 2000-12-28T05:00:00Z | 2000 | 12 | 2000-09-07T04:00:00Z | 2000-11-07T04:59:59Z | 2025-06-12T20:27:59Z | 00-22951 | 0 | 0 | 09000064804aeef1 |
| FDA-2000-N-0044-0001 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables - Notice of Proposed Rule (part 3 of 3) | Notice | NPR-Notice of Proposed Rule-Making | 2000-12-27T05:00:00Z | 2000 | 12 | 2000-12-27T05:00:00Z | 2001-03-23T04:59:59Z | 2011-06-11T16:25:50Z | 0 | 0 | 09000064804aefe4 | |
| FDA-2000-N-0044-0002 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables - Notice of Proposed Rule (part 1 of 3) | Notice | NPR-Notice of Proposed Rule-Making | 2000-12-27T05:00:00Z | 2000 | 12 | 2000-12-27T05:00:00Z | 2001-03-23T04:59:59Z | 2011-06-11T16:25:48Z | 0 | 0 | 09000064804af000 | |
| FDA-2000-M-0122-0001 | FDA | PMA Medtronic IsoMed Constant Flow Infusion System P990034 FDA-2000-M-0122 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2025-07-09T22:50:06Z | 00-31960 | 0 | 0 | 09000064804cf359 | ||
| FDA-2000-M-0123-0001 | FDA | PMA Apligraf (Graftskin) P950032/S016 FDA-2000-M-0123 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2025-07-09T23:30:31Z | 00-31960 | 0 | 0 | 09000064804cf3cb | ||
| FDA-2000-M-0050-0001 | FDA | Premarket Approval for Chiron Corp. PSA2 Immunoassay on Chiron Diagnostics ACS:180 & ACS Approved 12/08/98, P920030/S002 FDA-2000-M-0050 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2017-09-29T13:19:49Z | 00-31960 | 0 | 0 | 09000064804af23a | ||
| FDA-2000-P-0210-0001 | FDA | Exempt Pharmacy Compounding systems/Class II Devices From PM-CLOSED FDA-2000-P-0210 | Notice of Exemption | Notice | General Notice | 2000-12-27T05:00:00Z | 2000 | 12 | 2000-12-27T05:00:00Z | 2001-01-17T04:59:59Z | 2024-07-31T15:27:14Z | 0 | 0 | 09000064804d4c10 | |
| FDA-2000-M-0177-0001 | FDA | PMA FocalSeal-L Synthetic Absorbable Sealant P990028 FDA-2000-M-0177 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2025-07-09T23:05:47Z | 00-31960 | 0 | 0 | 09000064804d2768 | ||
| FDA-2000-M-0167-0001 | FDA | PMA Bayer Immuno 1 Complexed PSA Assay, P990055 FDA-2000-M-0167 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2025-07-21T23:25:52Z | 00-31960 | 0 | 0 | 09000064804d23dd | ||
| FDA-2000-M-0178-0001 | FDA | PMA AIA-Pack PA, P910065/S001 FDA-2000-M-0178 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2025-07-21T23:15:54Z | 00-31960 | 0 | 0 | 09000064804d27c8 | ||
| FDA-2000-M-0117-0001 | FDA | PMA Matritech NMP22 Test Kit, P940035/S002 FDA-2000-M-0117 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2025-07-21T22:48:43Z | 00-31960 | 0 | 0 | 09000064804cf1d7 | ||
| FDA-2000-M-0019-0001 | FDA | Medstone STS Lithotripter for treatment of gallstones FDA-2000-M-0019 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2025-07-09T23:38:44Z | 00-31960 | 0 | 0 | 09000064804ae968 | ||
| FDA-2000-N-0044-0003 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables - Notice of Proposed Rule (part 2 of 3) | Notice | NPR-Notice of Proposed Rule-Making | 2000-12-27T05:00:00Z | 2000 | 12 | 2000-12-27T05:00:00Z | 2001-03-23T04:59:59Z | 2011-06-11T16:25:49Z | 0 | 0 | 09000064804af001 | |
| FDA-2000-M-0121-0001 | FDA | PMA Carpentier-Edwards PERIMOUNT Pericardial Bioprosthesis FDA-2000-M-0121 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2025-07-09T22:42:27Z | 00-31960 | 0 | 0 | 09000064804cf2f1 | ||
| FDA-2000-M-0093-0001 | FDA | PMA Chilli Cooled Ablation System P990054 FDA-2000-M-0093 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-12-27T05:00:00Z | 2000 | 12 | 2025-07-11T16:08:10Z | 00-31960 | 0 | 0 | 09000064804b81ad | ||
| FDA-2000-D-0598-0001 | FDA | Genotoxicity Studies (VICH GL23) FDA-2000-D-0598 | International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); Draft Guidance for Industry on Safety Studies for Veterinary Drug Residues in Human Food: Genotoxicity Studies (VICH GL23); Availability; Request for Comments | Notice | Notice of Data Availability | 2000-12-18T05:00:00Z | 2000 | 12 | 2000-12-18T05:00:00Z | 2001-01-18T04:59:59Z | 2013-08-11T04:11:06Z | 0 | 0 | 09000064804dd8b2 | |
| FDA-2000-P-0066-0001 | FDA | Reclassify Barium Enema Retention Catheter to Class II FDA-2000-P-0066 | Notice of Final Rule: Medical Device; Exemption From Premarket Notification; Class II Devices; Barium Enema Retention Catheters and Tips With or Without a Bag | Notice | Notice of Final Rule | 2000-12-14T05:00:00Z | 2000 | 12 | 2026-01-22T22:35:19Z | 0 | 0 | 09000064804afc70 | |||
| FDA-1997-C-0030-0003 | FDA | Amend Regulations to Provide the Safe Use of Zinc Sulfide FDA-1997-C-0030 | Listing of Color Additives Exempt From Certification; Luminescent Zinc Sulfide; Correction | Notice | Correction | 2000-12-14T05:00:00Z | 2000 | 12 | 2024-12-10T17:56:44Z | 0 | 0 | 09000064805ca385 | |||
| FDA-1997-P-0017-0001 | FDA | Require that warning labels about risks of salmonella enteri FDA-1997-P-0017 | Food Labeling Safe Handling Statements,Labeling of Shell Eggs; Refrigeration of Shell Eggs Held for Retail Distribution; Notice of Final Rule | Notice | NFR-Notice of Final Rule | 2000-12-06T05:00:00Z | 2000 | 12 | 2015-05-20T15:06:16Z | 0 | 0 | 09000064805c9c5f | |||
| FDA-1991-F-0007-0001 | FDA | Resinous and Polymeric Coatings FDA-1991-F-0007 | FDA | Notice | NWL-Notice of Withdrawl | 2000-12-05T05:00:00Z | 2000 | 12 | 2008-05-16T23:37:54Z | 0 | 0 | 0900006480525a52 | |||
| FDA-1994-P-0041-0003 | FDA | Require Labeling of Trans Fatty Acid & Prohibit Deceptive Claims-CLOSED FDA-1994-P-0041 | FDA | Notice | NEC-Notice of Extension | 2000-12-05T05:00:00Z | 2000 | 12 | 2000-12-05T05:00:00Z | 2001-01-20T04:59:59Z | 2008-05-16T23:20:38Z | 0 | 0 | 09000064804feb07 | |
| FDA-2000-F-0115-0001 | FDA | Stabilizer in Olefin Polymers/Safe Use in Food Contact FDA-2000-F-0115 | [Docket Nos. 821;-0349,90F-0188,91F-0169,93F-0157,93F-0199,95F-0011,96F-0032, 96F- 0223,98F-0226,98F-0288,98F-0289,99F-0052,99F-0460,99F-1074,99F-2244,99F-2245, 99F-50 12, and OOF-00891 | Notice | Withdrawal | 2000-12-05T00:00:00Z | 2000 | 12 | 2025-05-21T19:30:55Z | 0 | 0 | 09000064804cf0fa | |||
| FDA-2000-D-0105-0001 | FDA | Medical Devices Guidance for Prescription Drugs Abuse Assays FDA-2000-D-0105 | FDA | Notice | NAD-Notice of Availability of Data | 2000-11-22T05:00:00Z | 2000 | 11 | 2000-11-22T05:00:00Z | 2001-02-13T04:59:59Z | 2008-04-25T01:32:13Z | 0 | 0 | 09000064804c248f | |
| FDA-1999-D-0044-0001 | FDA | (OTC) Screening Tests for Drugs of Abuse guidance for premar FDA-1999-D-0044 | FDA | Notice | NAD-Notice of Availability of Data | 2000-11-22T05:00:00Z | 2000 | 11 | 2000-11-22T05:00:00Z | 2001-02-13T04:59:59Z | 2018-08-15T01:04:10Z | 0 | 0 | 09000064804a5f4d | |
| FDA-1997-D-0009-0004 | FDA | Use of IEC 60601 Standards; Medical Electrical; FDA-1997-D-0009 | Recognition List Number 004 | Notice | NAD-Notice of Availability of Data | 2000-11-15T05:00:00Z | 2000 | 11 | 2008-05-16T21:59:17Z | 0 | 0 | 09000064805c9a39 | |||
| FDA-2000-D-0100-0001 | FDA | Clinical Data In Marketing Applications FDA-2000-D-0100 | FDA | Notice | NAD-Notice of Availability of Data | 2000-11-11T05:00:00Z | 2000 | 11 | 2000-11-11T05:00:00Z | 2001-01-09T04:59:59Z | 2008-04-25T01:47:25Z | 0 | 0 | 09000064804c214d | |
| FDA-2000-N-0109-0001 | FDA | Enrofloxacin for Poultry: Opportunity for Hearing FDA-2000-N-0109 | Enrofloxacin for Poultry; Opportunity for Hearing | Notice | Notice of Opportunity of Hearing | 2000-11-02T05:00:00Z | 2000 | 11 | 2000-11-02T05:00:00Z | 2001-01-03T04:59:59Z | 2025-09-04T15:27:34Z | 00-27832 | 0 | 0 | 09000064804c2a0d |
| FDA-1999-F-0021-0002 | FDA | Irradiation in the Production, Processing & Handling of Food FDA-1999-F-0021 | Irradiation in the Production, Processing and Handling of Food; Notice of Final Rule | Notice | NFR-Notice of Final Rule | 2000-11-01T05:00:00Z | 2000 | 11 | 2000-11-01T05:00:00Z | 2000-11-30T04:59:59Z | 2011-07-20T15:50:56Z | 0 | 0 | 09000064804a5aca | |
| FDA-1999-D-0081-0002 | FDA | Testing for Replication Competent Retrovirus in Retroviral FDA-1999-D-0081 | "Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors;" Availability | Notice | Notice of Data Availability | 2000-10-24T04:00:00Z | 2000 | 10 | 2025-07-01T21:48:06Z | 00-26670 | 0 | 0 | 09000064804a6961 | ||
| FDA-2000-D-0028-0001 | FDA | Channels trade policy commodities with methyl parathion FDA-2000-D-0028 | Draft Guidance for Industry: Channels of Trade Policy for Commodities With Methyl Parathion Residues; Availability | Notice | Notice of Availability | 2000-10-16T04:00:00Z | 2000 | 10 | 2000-10-16T04:00:00Z | 2000-12-07T04:59:59Z | 2021-11-12T16:00:23Z | 0 | 0 | 09000064804aeb11 | |
| FDA-1997-C-0051-0002 | FDA | Amend regulation to provide safe use of astaxanthin FDA-1997-C-0051 | Listing of Color Additives Exempt from Certification; Phaffia Yeast; Confirmation of Effective Date | Notice | Notice of Confirmation of Effective Date | 2000-10-16T04:00:00Z | 2000 | 10 | 2024-11-25T15:30:11Z | 00-25704 | 0 | 0 | 09000064805cfcf5 | ||
| FDA-1991-F-0028-0001 | FDA | Resinous and Polymeric Coatings FDA-1991-F-0028 | W.R. Grace & Co.; Withdrawal of Food Additive Petition | Notice | Withdrawal | 2000-10-16T04:00:00Z | 2000 | 10 | 2023-08-09T18:20:00Z | 0 | 0 | 0900006480528968 | |||
| FDA-1997-C-0030-0002 | FDA | Amend Regulations to Provide the Safe Use of Zinc Sulfide FDA-1997-C-0030 | Listing of Color Additives Exempt From Certification; Luminescent Zinc Sulfide; Confirmation of Effective Date | Notice | Notice of Confirmation of Effective Date | 2000-10-16T04:00:00Z | 2000 | 10 | 2024-12-10T17:54:10Z | 0 | 0 | 09000064805ca384 | |||
| FDA-1991-N-0043-0016 | FDA | Antioxidant Vitamins & Cancer,Hlth. Claims & Label Statement FDA-1991-N-0043 | FDA | Notice | N-Notice | 2000-10-11T04:00:00Z | 2000 | 10 | 2008-05-16T23:40:52Z | 0 | 0 | 090000648052af62 | |||
| FDA-1991-N-0033-0017 | FDA | Fatty Acids & Heart Disease, Hlth.Claims & Label Statements FDA-1991-N-0033 | FDA | Notice | N-Notice | 2000-10-11T04:00:00Z | 2000 | 10 | 2008-05-16T23:40:27Z | 0 | 0 | 09000064805297be | |||
| FDA-1999-N-0035-0002 | FDA | Proposal to Debar Jay Marcus FDA-1999-N-0035 | Jay Marcus; Debarment Order | Notice | Statutory Debarment | 2000-10-03T04:00:00Z | 2000 | 10 | 2024-10-21T20:24:44Z | 00–25086 | 0 | 0 | 09000064804a5d4b | ||
| FDA-1994-N-0026-0002 | FDA | Rami Eisharaiha; Proposal to Debarment FDA-1994-N-0026 | Rami Elsharaiha; Debarment Order | Notice | Statutory Debarment | 2000-10-03T04:00:00Z | 2000 | 10 | 2024-06-10T15:11:58Z | 00–25087 | 0 | 0 | 09000064804fd2cc | ||
| FDA-1991-N-0043-0015 | FDA | Antioxidant Vitamins & Cancer,Hlth. Claims & Label Statement FDA-1991-N-0043 | FDA | Notice | NFR-Notice of Final Rule | 2000-10-03T04:00:00Z | 2000 | 10 | 2008-05-16T23:40:52Z | 0 | 0 | 090000648052af5b | |||
| FDA-1994-N-0052-0001 | FDA | Proposal to Debar Mohammad Uddin; NPH FDA-1994-N-0052 | Mohammad Uddin; Debarment Order | Notice | Statutory Debarment | 2000-10-03T04:00:00Z | 2000 | 10 | 2024-06-17T13:04:12Z | 00-25088 | 0 | 0 | 09000064805037b6 | ||
| FDA-1991-N-0033-0016 | FDA | Fatty Acids & Heart Disease, Hlth.Claims & Label Statements FDA-1991-N-0033 | FDA | Notice | NFR-Notice of Final Rule | 2000-10-03T04:00:00Z | 2000 | 10 | 2008-05-16T23:40:18Z | 0 | 0 | 090000648052979b | |||
| FDA-2000-N-0107-0001 | FDA | Agency Information Collection:Orphan Drugs FDA-2000-N-0107 | Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs | Notice | General Notice | 2000-09-25T04:00:00Z | 2000 | 9 | 2000-09-19T04:00:00Z | 2000-11-21T04:59:59Z | 2025-06-12T21:09:55Z | 00-23886 | 0 | 0 | 09000064804c25d8 |
| FDA-2000-N-0005-0003 | FDA | Administrative Detention and Banned Medical Devices FDA-2000-N-0005 | FDA | Notice | NAL-Notice of Approval | 2000-09-25T04:00:00Z | 2000 | 9 | 2008-04-25T00:52:11Z | 0 | 0 | 09000064804ae619 | |||
| FDA-1992-N-0056-0005 | FDA | Prescription Drug Marketing Act of 1987, Drug Amds of 1992 FDA-1992-N-0056 | Notice of Hearing Before Commissioner re Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements, and Administration Procedures; Public Hearing | Notice | Notice of Pre-Hearing Conference | 2000-09-25T04:00:00Z | 2000 | 9 | 2000-09-25T04:00:00Z | 2000-11-21T04:59:59Z | 2016-10-13T16:04:54Z | 0 | 0 | 090000648052bf6e | |
| FDA-2000-N-0078-0001 | FDA | Treshold of Regulation for Subances Used in Food-Contact FDA-2000-N-0078 | Agency Information Collection Activities: Proposed Collection; Comment Request; Extension; Threshold of Regulation for Substances Used in Food-Contact Articles | Notice | General Notice | 2000-09-25T04:00:00Z | 2000 | 9 | 2000-09-19T04:00:00Z | 2000-11-21T04:59:59Z | 2025-06-12T20:47:00Z | 00-23884 | 0 | 0 | 09000064804b7e69 |
| FDA-1997-N-0049-0001 | FDA | Petition for administrative stay of action FDA-1997-N-0049 | Agency Information Collection Activities; Proposed Collection; Comment Request; Petition for Administrative Stay of Action | Notice | General Notice | 2000-09-25T00:00:00Z | 2000 | 9 | 2000-09-25T04:00:00Z | 2000-11-25T04:59:59Z | 2025-05-16T00:13:21Z | 00-24537 | 0 | 0 | 09000064805cfcd5 |
| FDA-2000-N-0071-0002 | FDA | Medical Devices; CLIA Waiver Criteria Public Workshop FDA-2000-N-0071 | Medical Devices; CLIA Waiver Criteria; Public Workshop | Notice | Notice of Extension | 2000-09-22T04:00:00Z | 2000 | 9 | 2000-09-15T04:00:00Z | 2000-10-17T03:59:59Z | 2025-06-06T23:16:46Z | 00-23881 | 0 | 0 | 09000064804b0260 |
| FDA-2000-N-0077-0001 | FDA | Sterility Requirements for Aqueous-Based Drug Products FDA-2000-N-0077 | Agency Information Collection Activities; Proposed Collection; Comment Request; Sterility Requirements for Aqueous-Based Drug Products for Oral Inhalation | Notice | General Notice | 2000-09-20T04:00:00Z | 2000 | 9 | 2000-09-18T04:00:00Z | 2000-11-18T04:59:59Z | 2025-06-12T20:34:09Z | 00-23890 | 0 | 0 | 09000064804b7e4f |
| FDA-2000-N-0164-0002 | FDA | Use of the Term "Fresh" for Foods Processed w/Alt Nonthermal FDA-2000-N-0164 | HFS-822 | Notice | NEC-Notice of Extension | 2000-09-20T04:00:00Z | 2000 | 9 | 2000-09-20T04:00:00Z | 2000-11-21T04:59:59Z | 2008-04-25T01:16:45Z | 0 | 0 | 09000064804d20ff | |
| FDA-2000-N-0228-0003 | FDA | Agency Information Collection Food Safety Survey FDA-2000-N-0228 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; Food Safety Survey; Correction | Notice | Correction | 2000-09-20T04:00:00Z | 2000 | 9 | 2000-09-18T04:00:00Z | 2025-06-05T15:59:59Z | 00-23885 | 0 | 0 | 09000064804d55cb | |
| FDA-1994-N-0026-0001 | FDA | Rami Eisharaiha; Proposal to Debarment FDA-1994-N-0026 | Rami Elsharaiha; Proposal to Debar; Opportunity for a Hearing | Notice | Notice of Opportunity of Hearing | 2000-09-14T04:00:00Z | 2000 | 9 | 2024-06-10T15:12:27Z | 99-1034 | 0 | 0 | 09000064804fd2c3 | ||
| FDA-2000-P-0102-0002 | FDA | Health Claim: Vegetable Oil Sterol Esters & Coronary Heart Disease CLOSED 05/26/2020 FDA-2000-P-0102 | FDA | Notice | NIR-Notice of Interim Rule | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-14T04:00:00Z | 2000-11-23T04:59:59Z | 2008-04-25T01:47:38Z | 0 | 0 | 09000064804c22b6 | |
| FDA-2000-P-0102-0003 | FDA | Health Claim: Vegetable Oil Sterol Esters & Coronary Heart Disease CLOSED 05/26/2020 FDA-2000-P-0102 | FDA | Notice | NIR-Notice of Interim Rule | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-14T04:00:00Z | 2000-11-23T04:59:59Z | 2008-04-25T01:47:39Z | 0 | 0 | 09000064804c22b7 | |
| FDA-2000-P-0133-0003 | FDA | Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 | FDA | Notice | NIR-Notice of Interim Rule | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-14T04:00:00Z | 2000-11-23T04:59:59Z | 2008-04-25T01:16:05Z | 0 | 0 | 09000064804cfd10 | |
| FDA-2000-F-0014-0001 | FDA | Safe Use of Sodium Chlorite Solutions FDA-2000-F-0014 | Alcide Corp. | Notice | NFL-Notice of Filing | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-14T04:00:00Z | 2000-10-12T03:59:59Z | 2008-04-25T01:13:42Z | 0 | 0 | 09000064804ae901 | |
| FDA-2000-D-0029-0001 | FDA | Reproductive Toxicity Studies preventive vaccines Disease FDA-2000-D-0029 | FDA | Notice | NAD-Notice of Availability of Data | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-08T04:00:00Z | 2000-12-08T04:59:59Z | 2008-04-25T01:01:33Z | 0 | 0 | 09000064804aeb36 | |
| FDA-2000-P-0133-0002 | FDA | Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 | FDA | Notice | NIR-Notice of Interim Rule | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-14T04:00:00Z | 2000-11-23T04:59:59Z | 2008-04-25T01:16:04Z | 0 | 0 | 09000064804cfd0b | |
| FDA-2000-F-0084-0002 | FDA | Acidified Sodium Chlorite Solution as Antimicrobial Agent FDA-2000-F-0084 | FDA | Notice | NFL-Notice of Filing | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-14T04:00:00Z | 2000-10-12T03:59:59Z | 2008-04-25T01:01:22Z | 0 | 0 | 09000064804b8097 | |
| FDA-2000-P-0102-0001 | FDA | Health Claim: Vegetable Oil Sterol Esters & Coronary Heart Disease CLOSED 05/26/2020 FDA-2000-P-0102 | FDA | Notice | NIR-Notice of Interim Rule | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-14T04:00:00Z | 2000-11-23T04:59:59Z | 2008-04-25T01:47:38Z | 0 | 0 | 09000064804c22ac | |
| FDA-2000-N-0076-0003 | FDA | Investigational Device Exemptions, Reports and Records FDA-2000-N-0076 | Activities; Announcement of OMB Approval; Investigational Device Exemptions, Reports, and Records | Notice | Notice of Approval | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-12T04:00:00Z | 2025-06-04T23:39:04Z | 00-23327 | 0 | 0 | 09000064804b7e3a | |
| FDA-2000-N-0007-0001 | FDA | Export of Medical Devices Foreign Letters of Approval FDA-2000-N-0007 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; Export of Medical Devices-Foreign Letters of Approval | Notice | General Notice | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-12T04:00:00Z | 2000-10-13T03:59:59Z | 2025-06-05T23:55:14Z | 00-23326 | 0 | 0 | 09000064804ae662 |
| FDA-2000-P-0133-0001 | FDA | Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 | FDA | Notice | NIR-Notice of Interim Rule | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-14T04:00:00Z | 2000-11-23T04:59:59Z | 2008-04-25T01:16:04Z | 0 | 0 | 09000064804cfc48 | |
| FDA-2000-F-0084-0001 | FDA | Acidified Sodium Chlorite Solution as Antimicrobial Agent FDA-2000-F-0084 | FDA | Notice | NFL-Notice of Filing | 2000-09-14T04:00:00Z | 2000 | 9 | 2000-09-14T04:00:00Z | 2000-10-12T03:59:59Z | 2008-04-25T01:01:22Z | 0 | 0 | 09000064804b807e | |
| FDA-2000-F-0147-0001 | FDA | Safe use of ozone in gaseous & aqueous phases as antimicrobi FDA-2000-F-0147 | Electric Power Research Institute, Agriculture and Food Technology Alliance; Filing of Food Additive Petition | Notice | Notice of Filing | 2000-09-13T04:00:00Z | 2000 | 9 | 2025-08-06T21:39:45Z | 0 | 0 | 09000064804d0fb2 | |||
| FDA-2000-D-0159-0001 | FDA | Waiver for Immediate Release Solid Oral Dosage Forms Based FDA-2000-D-0159 | FDA | Notice | NAD-Notice of Availability of Data | 2000-09-12T04:00:00Z | 2000 | 9 | 2008-04-25T01:16:07Z | 0 | 0 | 09000064804d17eb | |||
| FDA-2000-N-0012-0003 | FDA | Request for Samples & Protocols; Agency Information Collection Activities FDA-2000-N-0012 | Agency Information Collection Activities; Announcement of OMB Approval; Request for Samples and Protocols | Notice | Notice of Approval | 2000-09-12T04:00:00Z | 2000 | 9 | 2000-09-07T04:00:00Z | 2025-06-04T23:18:45Z | 00-22850 | 0 | 0 | 09000064804ae8bf | |
| FDA-2000-N-0139-0001 | FDA | Changes to an Approved NDA or ANDA; Agency Information Collection FDA-2000-N-0139 | Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry: Changes to an Approved NDA or ANDA | Notice | General Notice | 2000-09-12T04:00:00Z | 2000 | 9 | 2000-09-07T04:00:00Z | 2000-11-07T04:59:59Z | 2025-06-12T20:06:56Z | 00-22948 | 0 | 0 | 09000064804d0b88 |
| FDA-2000-M-0237-0001 | FDA | PMA, Coherent Opal Photoactivator Laser, P990049 FDA-2000-M-0237 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-09-07T04:00:00Z | 2000 | 9 | 2025-06-27T21:20:58Z | 00-22700 | 0 | 0 | 09000064804d5932 | ||
| FDA-2000-P-0184-0001 | FDA | Totally Implanted Spinal Cord Stimulator FDA-2000-P-0184 | FDA | Notice | N-Notice | 2000-09-07T04:00:00Z | 2000 | 9 | 2000-09-07T04:00:00Z | 2000-10-07T03:59:59Z | 2009-04-03T15:16:25Z | 0 | 0 | 09000064804d2ab5 | |
| FDA-2000-M-0058-0001 | FDA | Cutting Balloon, P950020 FDA-2000-M-0058 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-09-07T04:00:00Z | 2000 | 9 | 2025-06-26T23:32:17Z | 00-22700 | 0 | 0 | 09000064804af5ac | ||
| FDA-2000-M-0232-0001 | FDA | H990012; TAS Ecarin Clotting Time Test FDA-2000-M-0232 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-09-07T04:00:00Z | 2000 | 9 | 2025-06-27T22:25:20Z | 00-22700 | 0 | 0 | 09000064804d5736 | ||
| FDA-2000-M-0231-0001 | FDA | P980008 LaserScan LSX Excimer Laser System FDA-2000-M-0231 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-09-07T04:00:00Z | 2000 | 9 | 2025-06-26T22:57:21Z | 00-22700 | 0 | 0 | 09000064804d56d7 | ||
| FDA-2000-M-0090-0001 | FDA | P970055; Biotrin Parvovirus B19 IgM Enzyme Immunoassay FDA-2000-M-0090 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-09-07T04:00:00Z | 2000 | 9 | 2025-06-25T22:49:37Z | 00-22700 | 0 | 0 | 09000064804b8156 | ||
| FDA-2000-M-0235-0001 | FDA | FloSeal Matrix, FloSeal Matrix Hemostatic Sealant & Proceed Hemostatic Sealant FDA-2000-M-0235 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | NAD-Notice of Availability of Data | 2000-09-07T04:00:00Z | 2000 | 9 | 2008-11-06T16:37:24Z | 0 | 0 | 09000064804d5854 | |||
| FDA-2000-M-0086-0001 | FDA | P990013; Collamer Ultraviolet Absorbing Posterior Chamber FDA-2000-M-0086 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-09-07T04:00:00Z | 2000 | 9 | 2025-06-26T22:39:12Z | 00-22700 | 0 | 0 | 09000064804b80e4 | ||
| FDA-2000-M-0176-0001 | FDA | PMA Visulas 690's Laser & Visulink PDT Adapter, P990048 FDA-2000-M-0176 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-09-07T04:00:00Z | 2000 | 9 | 2025-06-27T21:53:40Z | 00-22700 | 0 | 0 | 09000064804d26fa | ||
| FDA-2000-M-0091-0001 | FDA | H990008; Telescopic Plate Space (TPS) Spinal System FDA-2000-M-0091 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-09-07T04:00:00Z | 2000 | 9 | 2025-06-26T21:57:16Z | 00-22700 | 0 | 0 | 09000064804b8173 | ||
| FDA-2000-M-0204-0001 | FDA | P970054; Biotrin Parvovirus B19 IgG Enzyme Immunoassay FDA-2000-M-0204 | Medical Devices; Availability of Safety and Effectiveness Summaries for PMA | Notice | Notice of Data Availability | 2000-09-07T04:00:00Z | 2000 | 9 | 2025-06-25T23:38:09Z | 00-22700 | 0 | 0 | 09000064804d4a59 | ||
| FDA-1998-N-0041-0006 | FDA | Elimination of establishment license/product license FDA-1998-N-0041 | Biological Products Regulated Under Section 351 of the Public Health Service Act; Implementation of Biologics License; Elimination of Establishment License and Product License; Technical Amendment | Notice | Notice of Final Rule | 2000-09-06T04:00:00Z | 2000 | 9 | 2026-01-30T22:48:35Z | 0 | 0 | 090000648056e5b2 | |||
| FDA-2000-D-0195-0001 | FDA | Analytical procedures and methods validation; drug substance FDA-2000-D-0195 | HFD-210 & HFM-40 | Notice | NAD-Notice of Availability of Data | 2000-09-01T04:00:00Z | 2000 | 9 | 2000-09-01T04:00:00Z | 2000-11-09T04:59:59Z | 2008-04-25T01:14:14Z | 0 | 0 | 09000064804d44d0 | |
| FDA-1995-N-0030-0001 | FDA | Substances Appoved use in Preparation Meat/Poultry Products FDA-1995-N-0030 | Substances Approved for Use in the Preparation of Meat and Poultry Products | Notice | Notice of Final Rule | 2000-08-28T04:00:00Z | 2000 | 8 | 2000-08-25T04:00:00Z | 2000-10-25T03:59:59Z | 2024-08-12T12:59:50Z | 00-21693 | 0 | 0 | 090000648055a5e9 |
| FDA-1993-F-0053-0001 | FDA | Safe use pentaerythritol mixed esters of C16-18 fatty acids FDA-1993-F-0053 | Cognis Corporation; Withdrawal of Food Additive Petition | Notice | Withdrawal | 2000-08-25T04:00:00Z | 2000 | 8 | 2024-05-03T13:25:43Z | 0 | 0 | 09000064804fc5be | |||
| FDA-2000-N-0228-0002 | FDA | Agency Information Collection Food Safety Survey FDA-2000-N-0228 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; Food Safety Survey | Notice | General Notice | 2000-08-25T04:00:00Z | 2000 | 8 | 2000-08-18T04:00:00Z | 2000-09-19T03:59:59Z | 2025-06-05T15:58:08Z | 00-21007 | 0 | 0 | 09000064804d55ca |
| FDA-2000-N-0079-0001 | FDA | User Fee Cover Sheet; Form FDA 3397 FDA-2000-N-0079 | Agency Information Collection Activities: Proposed Collection; Comment Request; User Fee Cover Sheet; Form FDA 3397 | Notice | General Notice | 2000-08-25T04:00:00Z | 2000 | 8 | 2000-08-18T04:00:00Z | 2000-10-08T03:59:59Z | 2025-06-12T20:00:28Z | 00-21011 | 0 | 0 | 09000064804b7e85 |
| FDA-2000-N-0080-0001 | FDA | Infant Formula Requirements FDA-2000-N-0080 | Agency Information Collection Activities; Proposed Collection; Comment Request; Infant Formula Requirements | Notice | General Notice | 2000-08-25T04:00:00Z | 2000 | 8 | 2000-08-18T04:00:00Z | 2000-10-18T03:59:59Z | 2025-06-12T20:03:10Z | 00-21009 | 0 | 0 | 09000064804b7ea3 |
| FDA-1998-F-0057-0001 | FDA | Safe Use of 3-iodo-2-propynyl butyl carbamate FDA-1998-F-0057 | Troy Corporation; Withdrawal of Food Additive Petition | Notice | Withdrawal | 2000-08-25T00:00:00Z | 2000 | 8 | 2025-05-21T23:09:39Z | 0 | 0 | 0900006480571adb | |||
| FDA-2000-N-0046-0001 | FDA | Importer's Entry Notice; Agency Information Collection Activities FDA-2000-N-0046 | Agency Information Collection Activities; Announcement of OMB Approval; Electronic Importer's Entry Notice | Notice | Notice of Approval | 2000-08-24T04:00:00Z | 2000 | 8 | 2000-08-23T04:00:00Z | 2025-06-04T23:14:05Z | 00-21478 | 0 | 0 | 09000064804af164 | |
| FDA-2000-D-0160-0001 | FDA | M4 Common Technical Document; International Conference on Harmonisation FDA-2000-D-0160 | FDA | Notice | NAD-Notice of Availability of Data | 2000-08-24T04:00:00Z | 2000 | 8 | 2000-08-24T04:00:00Z | 2000-10-01T03:59:59Z | 2008-04-25T01:44:26Z | 0 | 0 | 09000064804d1849 | |
| FDA-2000-N-0227-0001 | FDA | Substantial Evidence Effectiveness of New Animal Drugs FDA-2000-N-0227 | HFA-250 | Notice | N-Notice | 2000-08-17T04:00:00Z | 2000 | 8 | 2000-08-17T04:00:00Z | 2000-10-17T03:59:59Z | 2008-04-25T01:19:55Z | 0 | 0 | 09000064804d5543 | |
| FDA-2000-D-0137-0001 | FDA | Surveillance & Detention w/o Physical Examination of Condoms FDA-2000-D-0137 | Guidance for Industry; Surveillance and Detention Without Physical Examination of Condoms; Availability | Notice | NAD-Notice of Availability of Data | 2000-08-16T04:00:00Z | 2000 | 8 | 2000-08-16T04:00:00Z | 2000-11-14T04:59:59Z | 2008-07-11T17:13:51Z | 0 | 0 | 09000064804d0ab7 | |
| FDA-2000-N-0190-0002 | FDA | Egg Safety Action Plan FDA-2000-N-0190 | Meeting on 7/31/00 | Notice | NM-Notice of Meeting | 2000-08-14T04:00:00Z | 2000 | 8 | 2000-08-14T04:00:00Z | 2000-08-15T03:59:59Z | 2008-04-25T01:17:37Z | 0 | 0 | 09000064804d2eca | |
| FDA-2000-D-0103-0001 | FDA | Botanical Drug Development FDA-2000-D-0103 | FDA | Notice | NAD-Notice of Availability of Data | 2000-08-11T04:00:00Z | 2000 | 8 | 2000-08-11T04:00:00Z | 2000-11-11T04:59:59Z | 2008-04-25T01:44:05Z | 0 | 0 | 09000064804c2315 | |
| FDA-2000-N-0114-0001 | FDA | Revisions of Certain Food Chemicals Codex Monongraphs FDA-2000-N-0114 | Revisions of Certain Food Chemicals Codex Monographs, New General Test Procedures, Revisions of General Test Procedures, and Revisions of Test Solutions; Opportunity for Public Comment | Notice | General Notice | 2000-08-10T04:00:00Z | 2000 | 8 | 2000-08-08T04:00:00Z | 2000-09-23T03:59:59Z | 2025-06-06T22:09:59Z | 00-19993 | 0 | 0 | 09000064804cf083 |
| FDA-1997-C-0030-0001 | FDA | Amend Regulations to Provide the Safe Use of Zinc Sulfide FDA-1997-C-0030 | Listing of Color Additives Exempt From Certification; Luminescent Zinc Sulfide | Notice | Notice of Final Rule | 2000-08-10T04:00:00Z | 2000 | 8 | 2024-12-10T17:51:49Z | 0 | 0 | 09000064805ca381 | |||
| FDA-2000-F-0146-0002 | FDA | Safe Use of Calcium Disodium EDTA FDA-2000-F-0146 | Food Additives Permitted for Direct Addition to Food for Human Consumption; Calcium Disodium EDTA and Disodium EDTA | Notice | Notice of Final Rule | 2000-08-10T00:00:00Z | 2000 | 8 | 2025-05-21T21:00:11Z | 0 | 0 | 09000064804d0f61 | |||
| FDA-1999-N-0138-0001 | FDA | New Animal Drug Applications; Sheep as a Minor Species FDA-1999-N-0138 | New Animal Drug Applications; Sheep as a Minor Species | Notice | Notice of Final Rule | 2000-08-07T04:00:00Z | 2000 | 8 | 2024-10-17T17:58:21Z | 00-19627 | 0 | 0 | 09000064804aeddb | ||
| FDA-2000-D-0002-0001 | FDA | Q7A ICH Good Manufacturing Practice Guide for Active Pharmaceuticals FDA-2000-D-0002 | FDA | Notice | NAD-Notice of Availability of Data | 2000-08-07T04:00:00Z | 2000 | 8 | 2000-08-07T04:00:00Z | 2000-10-21T03:59:59Z | 2008-04-25T01:13:52Z | 0 | 0 | 09000064804ae573 | |
| FDA-2000-N-0071-0001 | FDA | Medical Devices; CLIA Waiver Criteria Public Workshop FDA-2000-N-0071 | Medical Devices; CLIA Waiver Criteria; Public Workshop | Notice | Meeting | 2000-08-01T04:00:00Z | 2000 | 8 | 2000-07-21T04:00:00Z | 2025-06-06T22:26:40Z | 00-18456 | 0 | 0 | 09000064804b024a | |
| FDA-1998-F-0072-0002 | FDA | safe use of ionizing radition for reduction of salmonella. CLOSED FDA-1998-F-0072 | FDA | Notice | NFR-Notice of Final Rule | 2000-07-31T04:00:00Z | 2000 | 7 | 2000-07-31T04:00:00Z | 2000-08-22T03:59:59Z | 2008-05-16T21:24:39Z | 0 | 0 | 0900006480583c7b | |
| FDA-1998-D-0035-0003 | FDA | Medical imaging drugs and biologics FDA-1998-D-0035 | FDA | Notice | NAD-Notice of Availability of Data | 2000-07-31T04:00:00Z | 2000 | 7 | 2000-07-31T04:00:00Z | 2000-09-30T03:59:59Z | 2008-05-16T21:18:12Z | 0 | 0 | 0900006480565915 | |
| FDA-2000-N-0223-0001 | FDA | Safe processing/importing of fish & fishery products FDA-2000-N-0223 | Agency Information Collection Activities; Proposed Collection; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products | Notice | General Notice | 2000-07-31T04:00:00Z | 2000 | 7 | 2000-07-21T04:00:00Z | 2000-09-20T03:59:59Z | 2025-06-06T22:12:56Z | 00-18459 | 0 | 0 | 09000064804d53e2 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);